Carregant...
BTK/ITK dual inhibitors: Modulating immunopathology and lymphopenia for COVID-19 therapy
Bruton’s tyrosine kinase (BTK) signaling is involved in innate immune responses and regulates the production of proinflammatory cytokines that can contribute to COVID-19 immunopathology. Clinical trials with BTK inhibitors in COVID-19 treatment have been proposed, and previous studies have attempted...
Guardat en:
| Publicat a: | J Leukoc Biol |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Oxford University Press
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7361550/ https://ncbi.nlm.nih.gov/pubmed/32640487 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/JLB.5COVR0620-306R |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|